|
|
Volumn 33, Issue SUPPL. 13, 2006, Pages
|
|
Current standards for response evaluation by imaging techniques
|
|
Author keywords
Anatomical imaging; Functional imaging; Response rates
|
|
Indexed keywords
ANGIOGENESIS INHIBITOR;
ANTINEOPLASTIC AGENT;
CYTOSTATIC AGENT;
FLUORODEOXYGLUCOSE F 18;
RECEPTOR BLOCKING AGENT;
DIAGNOSTIC AGENT;
RADIOPHARMACEUTICAL AGENT;
ACCURACY;
ANATOMY;
ARTICLE;
CANCER INHIBITION;
CELL KILLING;
COMPUTER ASSISTED TOMOGRAPHY;
EVALUATION;
HUMAN;
IMAGING SYSTEM;
MEASUREMENT;
METABOLISM;
NUCLEAR MAGNETIC RESONANCE IMAGING;
POSITRON EMISSION TOMOGRAPHY;
STANDARD;
TUMOR VOLUME;
NEOPLASM;
PHASE 2 CLINICAL TRIAL;
SCINTISCANNING;
DIAGNOSTIC ACCURACY;
DIAGNOSTIC IMAGING;
DIAGNOSTIC VALUE;
IMAGE QUALITY;
REVIEW;
TUMOR GROWTH;
WORLD HEALTH ORGANIZATION;
CLINICAL TRIALS, PHASE II;
FLUORODEOXYGLUCOSE F18;
HUMANS;
NEOPLASMS;
RADIONUCLIDE IMAGING;
RADIOPHARMACEUTICALS;
TOMOGRAPHY, X-RAY COMPUTED;
|
|
EID: 33746561201
PISSN: 16197070
EISSN: None
Source Type: Journal
DOI: 10.1007/s00259-006-0130-6 Document Type: Article |
|
Times cited : (16)
|
|
References (6)
|
